New Issue: Orbital Catastrophe Ahead? Read Now

Tackling Malaria

Interventions available today could lead to decisive gains in prevention and treatment--;if only the world would apply them

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Long ago in the Gambia, West Africa, a two-year-old boy named Ebrahim almost died of malaria. Decades later Dr. Ebrahim Samba is still reminded of the fact when he looks in a mirror. That is because his mother--;who had already buried several children by the time he got sick--;scored his face in a last-ditch effort to save his life. The boy not only survived but eventually became one of the most well-known leaders in Africa: Regional Director of the World Health Organization.

Needless to say, scarification is not what rescued Ebrahim Samba. The question is, What did? Was it the particular strain of parasite in his blood that day, his individual genetic or immunological makeup, his nutritional state? After centuries of fighting malaria--;and conquering it in much of the world--;it is amazing what we still do not know about the ancient scourge, including what determines life and death in severely ill children in its clutches. Despite such lingering questions, however, today we stand on the threshold of hope. Investigators are studying malaria survivors and tracking many other leads in efforts to develop vaccines. Most important, proven weapons--;principally, insecticide-treated bed nets, other antimosquito strategies, and new combination drugs featuring an ancient Chinese herb--;are moving to the front lines.

Claire Panosian Dunavan is professor of medicine at the University of California at Los Angeles School of Medicine, a specialist in infectious and tropical diseases, and a medical journalist. Her father served nine months on Guadalcanal in 1942-43, where he, like many others, suffered repeated attacks of malaria.

More by Claire Panosian Dunavan
Scientific American Magazine Vol 293 Issue 6This article was published with the title “Tackling Malaria” in Scientific American Magazine Vol. 293 No. 6 ()
doi:10.1038/scientificamerican122005-4zSSvP5gpjo0WdnTc7ZiS0

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe